Scollr summary
What this paper is about
GAN-based augmentation can strengthen PCA–LDA classification of whole-blood Raman spectra, particularly for patient-aware detection of breast-cancer spectra, but larger multicentre datasets and external validation are required before clinical applicability can be established.
Full abstract
Read the full abstract
Background: Whole-blood Raman spectroscopy provides a label-free molecular fingerprint with potential for breast-cancer classification, but limited sample sizes and substantial biological variability can restrict model generalization. This study evaluated whether generative adversarial network (GAN) augmentation could improve PCA–LDA classification while preserving patient-independent evaluation. Methods: Whole-blood Raman spectra from breast-cancer patients and healthy controls across Stages I–III were analysed using PCA–LDA under four data-composition scenarios: RealOnly, Real25, Real50 and Real100, corresponding to 0%, 25%, 50% and 100% synthetic augmentation. Vanilla GAN and conditional GAN (cGAN) data were evaluated using SpectrumKFold, SubjectKFold and leave-one-patient-out cross-validation (LOPOCV). Classification performance was assessed using accuracy, sensitivity, specificity, balanced accuracy, F1-score, MCC and ROC-AUC, with spectral correspondence and prediction confidence additionally examined. Results: Spectrum-level validation frequently produced near-perfect discrimination, whereas patient-aware validation produced more conservative performance, demonstrating the influence of inter-patient variability. GAN augmentation generally improved sensitivity, balanced accuracy, F1-score and MCC, with the largest benefits observed for the more challenging patient-aware settings. cGAN generally produced greater improvements than vanilla GAN and frequently achieved strong performance at lower augmentation levels. Under LOPOCV, for example, Stage II sensitivity increased from 79.09% with real data alone to 87.32% with 25% cGAN augmentation, while Stage III sensitivity increased from 75.23% to 82.98%. Stage III remained the most challenging setting, with RealOnly LOPOCV AUC of 0.9521 compared with 0.9918 for Stage II. Conclusion: GAN-based augmentation can strengthen PCA–LDA classification of whole-blood Raman spectra, particularly for patient-aware detection of breast-cancer spectra. cGAN showed greater augmentation efficiency than vanilla GAN in several settings. However, the small number of patients within individual stages and absence of independent external validation limit generalizability. Larger multicentre datasets and external validation are required before clinical applicability can be established.
Direct answer
What can I do from this paper page?
Use this page to scan "Generative Adversarial Network Augmentation of Whole-Blood Raman Spectra for Breast-Cancer Classification: A PCA–LDA and Patient-Aware Validation Study" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Spectroscopy Techniques in Biomedical and Chemical Research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Mairura2026Generative,
title = {Generative Adversarial Network Augmentation of Whole-Blood Raman Spectra for Breast-Cancer Classification: A PCA–LDA and Patient-Aware Validation Study},
author = {Brian O. Mairura and John Githaiga and Ruth W. Ndung'u},
journal = {Asian Journal of Probability and Statistics},
year = {2026},
doi = {10.9734/ajpas/2026/v28i11971},
url = {https://doi.org/10.9734/ajpas/2026/v28i11971}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Spectroscopy Techniques in Biomedical and Chemical Research papers?
Follow Spectroscopy Techniques in Biomedical and Chemical Research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Generative Adversarial Network Augmentation of Whole-Blood Raman Spectra for Breast-Cancer Classification: A PCA–LDA and Patient-Aware Validation Study. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app